🔗 Permalink

Inventor profile of:

Ivan Bieche

City:

Suresnes

Country:

France

Published Applications:

8

Last publication date:

2022-06-30

Top Assignees for applications by Ivan Bieche

The entities that hold a legal rights for patent applications filed by inventor Bieche Ivan:

Assistance Publique-Hopitaux De Paris 4 Paris, France
ARIANA PHARMACEUTICALS 4 Paris, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 3 PARIS, France
Institut National de la Sante et de la Recherche Medicale 3 Paris, France
BIO-RAD EUROPE GMBH 2 Basel, Switzerland
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 2 Paris Cedex 16, France
BIO-RAD INNOVATIONS 1 Marns La Coquette, France
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 1 Paris Cedex 13, France
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER 1 Montpellier Cedex 5, France
INSTITUT CURIE 1 Paris Cedex 5, France
ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS 1 Paris, France
Universite Rene Descartes (Paris V) 1 Paris, France
Universite Montpellier 2 Sciences et Techniques 1 Montpellier Cedex 5, France
BIO-RAD INNOVATIONS 1 Marnes La Coquette, France
Universite Paris 7- Denis Diderot 1 Paris, France

Recent patent applications by Bieche Ivan

Ivan Bieche from Suresnes, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-06-30

US20220205039A1

Chemistry; metallurgy

Combination of biomarkers for detecting and evaluating a hepatic fibrosis

#2 | 2020-02-20

US20200056235A1

Chemistry; metallurgy

COMBINATION OF BIOMARKERS FOR DETECTING AND EVALUATING A HEPATIC FIBROSIS

#3 | 2017-10-05

US20170283871A1

Chemistry; metallurgy

Combination of biomarkers for detecting and evaluating a hepatic fibrosis

#4 | 2015-02-05

US20150038357A1

Chemistry; metallurgy

PROGNOSIS FOR GLIOMA

#5 | 2014-01-02

US20140005249A1

Chemistry; metallurgy

NKX2.2 INHIBITORS AS DRUGS

#6 | 2013-12-05

US20130323720A1

Chemistry; metallurgy

Combination of biomarkers for the detection and evaluation of hepatitis fibrosis

#7 | 2013-11-28

US20130316332A1

Chemistry; metallurgy

Combination of biomarkers for the prognosis of response or non-response to an anti-HCV treatment

#8 | 2010-07-22

US20100183555A1

METHODS AND KITS FOR DETERMINING DRUG SENSITIVITY IN PATIENTS INFECTED WITH HCV

InventorID:

547961 ⎘